Problem
Ineffective self-regulation in the pharmaceutical and medical devices industries
Incidence:
Although the pharmaceutical business itself is probably the most truly global of all industries, drug controls are managed on a very insular, national level, as though the rest of the world did not exist. Drugs are sold globally, but withdrawn nationally. Doctors in each country usually have to discover problems with a drug independently of those in other countries.
Broader Problems:
Unethical pharmaceutical practicesIneffective self-regulation in the health care sector Narrower Problems:
Inadequate testing of drugsRefusal to market new drugsInadequate drug classification Related Problems:
Excessive availability of contraceptivesRestrictive practices in trade in pharmaceutical products Aggravates:
Cultural bias in medicineInadequate health servicesHazardous medical use of silicon gelMarketing of banned pharmaceutical drugsArtificial manufacture of human hormonesConfusion among drugs with similar namesObstruction of governmental medical reformExcessive influence of pharmaceutical manufacturers over doctorsNon-responsiveness of transnational corporations to pharmaceutical needs Strategies:
Reforming pharmaceutical usage in public health Subject(s):
Amenities → EquipmentCybernetics → Control
Health Care → Pharmacy
Industry → Industry
Medicine → Medicine
Societal Problems → Ineffectiveness
Related UN Sustainable Development Goals:
Problem Type:
E: Emanations of other problems Date of last update
29.07.2021 – 06:35 CEST